Small ubiquitin-related modifier (SUMO) research requires large amounts of SUMO-activating enzyme (SUMO-E1) for in vitro SUMOylation assays. In this study the expression and purification of a hexahistidinetagged mouse Aos1-Uba2-fusion protein (His 6 -mAU) in a baculovirus-insect cell system revealed that approximately 1.0 mg of highly-purified His 6 -mAU was obtained from 100 mL of Sf9 cell culture. The recombinant protein had SUMO-E1 activity in multiple in vitro SUMOylation assays.
SUMOs can be covalently conjugated to lysine residues in eukaryotic cellular proteins. This biochemical process is referred to as SUMOylation. It is an important strategy used by a wide variety of eukaryotes to control the structures and functions of target proteins. 1, 2) SUMOylation involves an enzymatic cascade comprising at least two components: (i) the SUMOactivating enzyme, SUMO-E1, composed of a heterodimer of Aos1 and Uba2, and (ii) the SUMO-conjugating enzyme, SUMO-E2, known as Ubc9.
Current research in the SUMOylation field relies largely on in vitro SUMOylation assays, such as reconstitution of the conjugation reaction using purified recombinant proteins to determine SUMOylated sites on target proteins and the in situ SUMOylation assay to visualize regions where SUMOylation takes place in cells. [3] [4] [5] [6] A key component of these assays is, of course, the recombinant protein that shows SUMO-E1 activity.
We previously generated mouse Aos1-Uba2-chimeric fusion protein (mAU), and we found that recombinant His 6 -tagged and GST-tagged mAU expressed in Escherichia coli substituted for a heterodimer of Aos1/Uba2 and acted as SUMO-E1 in in vitro SUMOylation assay. 7, 8) However, we also realized that neither the quantity nor the quality of production of the recombinant mAU in E. coli was satisfactory. Very little soluble full-length His 6 -mAU was produced in E. coli under any growth condition, and GST-mAU expression was always associated with a large amount of multiple degraded/non-maturely-translated products, indicating a low yield of SUMO-E1 activity (data not shown).
To improve the yield and quality of recombinant mAU production, we tested a baculovirus-insect cell system. Here we present data on successful expression of His 6 -mAU in the baculovirus-insect cell system. The experimental procedures and details are and the results were as follows: To prepare a bacmid DNA vector for expression of His 6 -mAU in a baculovirus-insect cell system, pGEX-mAU plasmid was used as template in a polymerase chain reaction containing a 5 0 -sense primer (5 0 -ACGGTAGCGGCCGCCCGGGAGGAATGGTAG-AGAAGG-3 0 ) and 3 0 -antisense primer (5 0 -TATCTA-GACTAGTCTAACGCTATGACGTC-3 0 ). 7) The amplified fragment was digested with Xba I and Not I and cloned into pFastBacÔ (Invitrogen, Carlsbad, CA) vector, and was referred to as pFastBac-His 6 -mAU. The nucleotide sequence of both strands of the insert was confirmed by DNA sequencing (Operon Biotechnology, Tokyo). The DNA sequence is available upon request.
Sf9 insect cells were purchased from Invitrogen, and were maintained in Grace's Insect Medium (Gibco Life Technologies, Gaithersburg, MD), containing 10% fetal bovine serum and 100 units of penicillin. Transfection of the Sf9 cells with pFastBac-mAU and pFast Bac1 as control was performed following manufacturer's instructions (Bac-to-Bac, BEVS Manual, Invitrogen). The culture medium of the transfected cells was used in subsequent amplification of the virus. High-titer viral stocks were obtained by amplification on Sf9 cells in monolayer cell culture by multiplicity of infection.
To produce recombinant His 6 -mAU, a 10 mL culture of Sf9 cells in the monolayer (10 cm dishes, Corning, Corning, NY) was infected with recombinant His 6 -mAU-baculovirus. The cell density at the time of infection was 1{2 Â 10 7 cells/mL. As control, mockinfected cells were also cultured. After 3-4 d, the cells were harvested by centrifugation at 1;700 Â g for 10 min. A crude lysate was prepared by re-suspension of the cell pellets in phosphate-buffered saline (PBS) containing 0.1% triton X-100, followed by sonication. Insoluble materials were removed by centrifugation at 1;700 Â g for 10 min, and the supernatants were suby To whom correspondence should be addressed. Tel/Fax: +81-96-342-3450; E-mail: hisa@kumamoto-u.ac.jp Abbreviations: SUMO, small ubiquitin-related modifier; TDG, thymine DNA glycosylase; EGFP, enhanced green fluorescence protein; GST, glutathione S-transferase; His 6 , hexahistidine-tag; DAPI, 5,6-diamidino-2-phenylindole; ATP, adenosine triphosphate jected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), followed by Coomassie Brilliant Blue (CBB) staining. Remarkably, when compared with the mock-infected cell extracts, a band at about 130 kDa was readily detectable as a prominent band in the supernatants of the infected cells (Fig. 1B  arrowhead) . The 130-kDa band visualized by CBB appeared to represent His 6 -mAU, given that anti-Uba2 (Everest Biotech, Upper Heyford, UK; Fig. 1A ) and anti-His 6 (Santa Cruz Biotechnology, Santa Cruz, CA; data not shown) antibodies detected a band migrating at 130 kDa.
Next, to purify the 130-kDa band, 5 mL of the supernatant was incubated with 100 mL (bed volume) of NTA-agarose nickel affinity gel (Qiagen, Hamburg, Germany) for 10 min. After a short centrifugation to sediment the resin, the unbound materials were removed, and the resin was washed 3 times with 1 mL of PBS. The 130-kDa band was eluted from the resin with 3 Â 200 mL of PBS plus 100 mM imidazole, divided into small aliquots, frozen, and stored at À80 C. When the eluted samples were subjected to SDS-PAGE followed by CBB staining, we estimated that the 130-kDa band was 85% pure as judged by densitometric analysis of the CBB staining (Fig. 1C) . Immunoblot analysis revealed that the 130-kDa band was recognized by the anti-Aos1 (Fig. 1D) and anti-His 6 (data not shown) antibodies, suggesting that the 130-kDa protein of His-mAU was enriched efficiently by the single-affinity purification. We obtained 1.0-2.0 mg of the protein from 100 mL cell culture reproducibly by this protocol.
To confirm that the purified 130-kDa protein/His 6 -mAU exhibited SUMO-E1 activity, and thus was indeed applicable to in vitro SUMOylation assays, we performed two different types of in vitro experiments. First, a biochemical reconstitution experiment was conducted to generate SUMOylated protein in vitro. For this, we chose TDG as model substrate, given that it is a base-excision repair enzyme involved in DNA demethylation and is known to be an efficient substrate for SUMOylation.
9,10) TDG fused to GST (GST-TDG; 0.4 mg) and His 6 -Ubc9 (SUMO-E2; 0.2 mg) and His 6 -SUMO-1 (0.2 mg) were incubated with and without purified His 6 -mAU (0.3 mg) in 20 mL of reaction mixture containing 2 mM MgCl 2 and 1 mM ATP at 30 C for 20 min. The reaction mixtures were then subjected to immunoblot analysis using anti-GST antibody (Santa Cruz Biotechnology). As shown in Fig. 2A , in addition to the non-SUMOylated form of GST-TDG, which migrated at 90 kDa (27 kDa GST þ 63 kDa TDG), a prominent 110-kDa band was detected only in the reaction mixture supplemented with all the components, including purified His 6 -mAU, His 6 -Ubc9, and His 6 -SUMO-1, in the presence of Mg 2þ -ATP. Judging by the molecular weight, the 90-kDa band might have represented the mono-SUMOylated form of GST-TDG (90 kDa of GST-TDG þ 20 kDa of His 6 -SUMO-1). GST alone exhibited no SUMOylated signals even in the presence of all the SUMOylation components ( Fig. 2A right panel) , and the reaction mixture without His 6 -mAU exhibited no 110-kDa band of SUMOylated GST-TDG. These results indicate that GST-TDG was efficiently and specifically SUMOylated when purified His 6 -mAU was supplemented with His 6 -Ubc9 and His 6 -SUMO-1 in the presence of Mg 2þ -ATP, suggesting that recombinant His 6 -mAU expressed in the baculovirusinsect cell system shows SUMO-E1 activity.
Secondly, to evaluate further whether purified His 6 -mAU acts as SUMO-E1, another type of in vitro assay, designated the in situ SUMOylation assay, 5, 6) was performed. Briefly, HeLa cells were grown on a coverslip and then permeabilized for 5 min on ice with PBS plus 0.1% of triton X-100. After permeabilization, 50 mL of SUMOylation buffer containing His 6 -GFP-SUMO-1 (0.4 mg), 2 mM MgCl 2 , and 1 mM of ATP were added with and without purified His 6 -mAU (0.3 mg) and/or microscope (Olympus, Tokyo). As shown in Fig. 2B , the cells displayed enhanced nuclear distribution of GFP signals when treated with the SUMOylation buffer containing both purified His 6 -mAU and His 6 -Ubc9. In contrast, GFP signals in reaction containing the SUMOylation buffer without purified His 6 -mAU, His 6 -Ubc9, or either exhibited negligible GFP signals. Furthermore, immunoblot analysis of extracts from the in situ SUMOylation assay revealed an accumulation of high molecular mass His 6 -GFP-SUMO-1-conjugated proteins only in the in situ SUMOylation assay containing all the components, not in the assay lacking purified His 6 -mAU, His 6 -Ubc9, or both (Fig. 2C) . Taken together, these results indicate that both the purified His 6 -mAU and His 6 -Ubc9 were required to obtain positive signals in the in situ SUMOylation assay and to generate SUMOylated proteins during the in situ SUMOylation assay, confirming that the purified His 6 -mAU possessed SUMO-E1 activity.
In conclusion, we found for the first time that the baculovirus-insect cell expression system can be used for efficient production of recombinant His 6 -mAU. The expression of His 6 -mAU was readily detectable on SDS-PAGE as a prominent band at 130 kDa among numerous cellular proteins. The expressed His 6 -mAU was highly enriched by a single affinity purification step and showed SUMO-E1 activity. This should not only provide an opportunity to conduct multiple in vitro SUMOylation assays, but also has advantages for SUMO researchers who decide to perform biochemical characterization, screening for inhibitors, or structural studies for SUMO-E1. A, His 6 -mAU was expressed and purified as described in the text. GST-TDG, GST alone, His 6 -SUMO-1, and His 6 -Ubc9 (SUMO-E2) were expressed in E. coli and purified using appropriate affinity resins, as described previously. 7, 9) One and several of the SUMOylation components, as indicated in the figure, were incubated with GST-TDG (lanes 1, 2, 3 and 4) and GST alone (lanes 5 and 6), respectively, at 30 C for 60 min. þ indicates addition of the components, and À represents absence of the components. All the reactions contained His 6 -SUMO-1, MgCl 2 , and ATP. The reaction mixtures were subjected to SDS-PAGE, followed by immunoblot analysis with anti-GST antibody. The size marker proteins are shown on left side. The predicted positions of non-modified (90 kDa) and SUMOylated forms of GST-TDG (110 kDa) are represented by arrows. B, HeLa cells on a coverslip were permeabilized with 0.1% triton X-100 and mixed with 20 mL of in situ SUMOylation buffer supplemented with the purified protein (His 6 -mAU), His 6 -Ubc9, or both, as indicated in the figure. All reactions were incubated in the presence of His 6 -GFP-SUMO-1 and Mg 2þ -ATP. þ indicates the reaction mixture containing the indicated component, and À represents the reaction mixture without the indicated component. After fixation, GFP (larger panel) and DAPI (inset) signals were observed by fluorescence microscopy. Bars indicate 10 mm. C, After the in situ SUMOylation reaction, total cell lysate was prepared and subjected to SDS-PAGE, followed by immunoblot analysis with anti-GFP antibody (upper panel). þ indicates the reaction mixture containing the components described in the figure. À represents the reaction mixture without the components indicated in the figure. Arrow indicates the non-conjugated form of His 6 -GFP-SUMO-1. The vertical line shows cellular proteins conjugated to His 6 -GFP-SUMO-1. The same membrane was probed with anti--actin antibody, showing equal amounts of protein loaded in each of the lanes (bottom panel).
